Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reversible interstitial pneumonitis associated with low dose bleomycin.

T J O'Neill, C G Kardinal, L M Tierney

    Chest
    |August 1, 1975
    PubMed
    Summary

    Bleomycin treatment for nodular histiocytic lymphoma can cause interstitial pneumonitis. This pulmonary toxicity was observed at a lower dose than previously reported and was fully reversible in this patient.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
    Same author

    Real-world bone turnover marker use: impact on treatment decisions and fracture.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
    Same author

    A systematic review and meta-analysis of factors associated with anthelmintic resistance in sheep.

    Preventive veterinary medicine·2014
    Same author

    A comparison of the patient and surgeon opinion on the long-term aesthetic outcome of reduction mammaplasty: have we improved over 15 years?

    Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2014
    Same author

    Surgery's new frontier-the heart.

    Science in progress·2014
    Same author

    A systematic review and meta-analysis of phase I inactivated vaccines to reduce shedding of Coxiella burnetii from sheep and goats from routes of public health importance.

    Zoonoses and public health·2013

    Area of Science:

    • Oncology
    • Pulmonology
    • Pharmacology

    Background:

    • Nodular histiocytic lymphoma is a type of cancer.
    • Bleomycin is a chemotherapy agent used in treating various cancers.
    • Interstitial pneumonitis is a known potential side effect of bleomycin therapy.

    Purpose of the Study:

    • To report a case of interstitial pneumonitis following bleomycin treatment for nodular histiocytic lymphoma.
    • To document the specific dose of bleomycin associated with this complication.
    • To assess the reversibility of bleomycin-induced pulmonary toxicity.

    Main Methods:

    • A case study of a single patient.
    • Clinical observation of treatment response and adverse events.
    • Lung biopsy for histopathological confirmation of interstitial pneumonitis.

    Main Results:

    • The patient developed interstitial pneumonitis after receiving bleomycin for nodular histiocytic lymphoma.
    • The complication occurred at a lower bleomycin dose than previously documented in literature.
    • Pulmonary function tests and imaging indicated complete resolution of the pneumonitis.

    Conclusions:

    • Bleomycin-induced pulmonary toxicity can occur at lower doses than previously recognized.
    • Interstitial pneumonitis associated with bleomycin may be completely reversible.
    • Careful monitoring for pulmonary complications is essential during bleomycin therapy.

    Related Experiment Videos